Share of Clicks for top 10 US Pharma & Biotech Infectious Diseases brands
Here are the Top 10 competitors in the industry by Share of Clicks for the last month.
| Domain | Share of clicks |
|---|---|
| paxlovid.com | 14.49 |
| mavyret.com | 13.68 |
| uqora.com | 10.47 |
| admired.com | 9.7 |
| hellowisp.com | 5.18 |
| goodrx.com | 4.74 |
| cabenuva.com | 4.3 |
| gofreddie.com | 3.25 |
| mayoclinic.org | 2.6 |
| epclusa.com | 2.34 |
| others | 29.25 |
- paxlovid.com - 14.49%
- mavyret.com - 13.68%
- uqora.com - 10.47%
- admired.com - 9.7%
- hellowisp.com - 5.18%
- goodrx.com - 4.74%
- cabenuva.com - 4.3%
- gofreddie.com - 3.25%
- mayoclinic.org - 2.6%
- epclusa.com - 2.34%
- others - 29.25%
Copyright © Adthena. All rights reserved.
In the PPC landscape, ‘paxlovid.com’ leads with 14.49% click share, followed by ‘mavyret.com’ at 13.68%. ‘Others’ collectively hold a significant 29.25%.
Share of Spend for the top 10 US Pharma & Biotech Infectious Diseases brands
Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.
| Date | uqora.com | admired.com | cabenuva.com | dovato.com | mavyret.com | epclusa.com | hellowisp.com | goodrx.com | gofreddie.com | paxlovid.com |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/06/01 | 7.06% | 9.6% | 8.84% | 2.63% | 13.62% | 3.35% | 3.54% | 6.27% | 4.4% | 3.96% |
| 2026/06/02 | 8.52% | 8.55% | 9.01% | 3.4% | 10.08% | 5.63% | 5.82% | 6.89% | 3.63% | 4.33% |
| 2026/06/03 | 1.88% | 4.46% | 12.19% | 7.86% | 17.19% | 2.65% | 1.1% | 4.03% | 6.08% | 4.08% |
| 2026/06/04 | 4.36% | 4.14% | 13.18% | 2.45% | 14.47% | 2.78% | 5.14% | 3.7% | 3.4% | 4.57% |
| 2026/06/05 | 7.15% | 5.94% | 12.98% | 2.79% | 12.99% | 2.58% | 4.17% | 1.53% | 5.91% | 3.96% |
| 2026/06/06 | 10.74% | 9.97% | 8.33% | 1.74% | 11.96% | 2.41% | 5.64% | 4.68% | 3.39% | 4.15% |
| 2026/06/07 | 5.67% | 8.79% | 6.85% | 2.66% | 14.1% | 4.15% | 7.19% | 5.2% | 4.24% | 3.11% |
| 2026/06/08 | 6.97% | 7.74% | 11.18% | 4.03% | 15.5% | 3.47% | 5.85% | 2.52% | 5.4% | 3.98% |
| 2026/06/09 | 2.39% | 5.67% | 12.76% | 3.31% | 17.19% | 3.69% | 1.46% | 5.13% | 7.34% | 4.45% |
| 2026/06/10 | 6.12% | 4.84% | 9.91% | 5.25% | 15.59% | 5.39% | 4.82% | 3.15% | 4.87% | 4.94% |
| 2026/06/11 | 6.73% | 6.04% | 8.58% | 5.85% | 15.1% | 2.27% | 3.73% | 1.05% | 9.06% | 4.7% |
| 2026/06/12 | 13.23% | 12.28% | 8.85% | 0.61% | 9.49% | 2.41% | 5.7% | 3.31% | 7.06% | 5.1% |
| 2026/06/13 | 7.28% | 11.28% | 11.17% | 2.52% | 10.41% | 1.41% | 9.24% | 4.92% | 5.92% | 4% |
| 2026/06/14 | 8.45% | 11.04% | 11.63% | 2.85% | 9.9% | 1.92% | 7.09% | 5.29% | 7.36% | 4.12% |
| 2026/06/15 | 2.7% | 6.39% | 5.07% | 3.34% | 13.56% | 2.94% | 3.16% | 5.71% | 9.84% | 5.78% |
| 2026/06/16 | 6.86% | 7.87% | 7.27% | 6.81% | 14.37% | 1.94% | 3.67% | 7.31% | 6.03% | 3.78% |
| 2026/06/17 | 7.07% | 9.27% | 11.61% | 5.31% | 13.02% | 1.82% | 3.9% | 0% | 14.16% | 4.3% |
| 2026/06/18 | 12.59% | 8.81% | 9.52% | 3.78% | 12.35% | 4.02% | 4.88% | 0% | 4.23% | 4.04% |
| 2026/06/19 | 12.96% | 4.9% | 12.89% | 5.25% | 15.32% | 3.45% | 8.14% | 0.01% | 1.37% | 3.98% |
| 2026/06/20 | 8.88% | 0% | 12.39% | 7.79% | 18.26% | 3.18% | 0.07% | 0.03% | 2.14% | 5.99% |
| 2026/06/21 | 8.21% | 8.57% | 10.34% | 8.51% | 12.99% | 2.41% | 7.57% | 2.88% | 4.46% | 3.45% |
| 2026/06/22 | 8.61% | 9.94% | 7.38% | 9.57% | 8.46% | 3.29% | 6.81% | 4.44% | 2.51% | 4.06% |
| 2026/06/23 | 7.04% | 3.74% | 11.68% | 7.67% | 11.55% | 3.95% | 3.65% | 3.16% | 2.2% | 4.03% |
| 2026/06/24 | 4.58% | 0% | 21.17% | 9.29% | 10.89% | 3.95% | 0% | 0% | 1.21% | 6.26% |
| 2026/06/25 | 2.42% | 0% | 18.24% | 13.48% | 6.36% | 5% | 0% | 0% | 1.44% | 6.37% |
| 2026/06/26 | 2.65% | 0% | 19.55% | 10.61% | 15.2% | 4.07% | 0.18% | 0% | 0.52% | 6.84% |
| 2026/06/27 | 0% | 0% | 16.5% | 10.41% | 14.85% | 4.43% | 0% | 0% | 1.05% | 6.33% |
| 2026/06/28 | 4.8% | 5.28% | 16.1% | 7.55% | 12.23% | 5.46% | 2.65% | 2.19% | 1.86% | 4.94% |
| 2026/06/29 | 9.14% | 10.46% | 9.31% | 6.48% | 6.14% | 4.95% | 6.52% | 4.91% | 3.34% | 2.77% |
| 2026/06/30 | 13.55% | 12.04% | 8.92% | 7.53% | 7.1% | 4.31% | 4.25% | 3.97% | 0.92% | 0.69% |
- uqora.com
- admired.com
- cabenuva.com
- dovato.com
- mavyret.com
- epclusa.com
- hellowisp.com
- goodrx.com
- gofreddie.com
- paxlovid.com
Copyright © Adthena. All rights reserved.
In June 2026, Cabenuva.com led with a peak on June 24 at 21.17. Mavyret.com followed closely, peaking on June 20 at 18.26. Uqora.com and Admired.com showed consistent fluctuations, while Paxlovid.com ended with a decline.
Competitor Count for US Pharma & Biotech Infectious Diseases
Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.
| Date | Competitor Count |
|---|---|
| 2026/06/01 | 73 |
| 2026/06/02 | 72 |
| 2026/06/03 | 70 |
| 2026/06/04 | 75 |
| 2026/06/05 | 76 |
| 2026/06/06 | 76 |
| 2026/06/07 | 79 |
| 2026/06/08 | 77 |
| 2026/06/09 | 72 |
| 2026/06/10 | 73 |
| 2026/06/11 | 71 |
| 2026/06/12 | 75 |
| 2026/06/13 | 75 |
| 2026/06/14 | 75 |
| 2026/06/15 | 71 |
| 2026/06/16 | 70 |
| 2026/06/17 | 71 |
| 2026/06/18 | 66 |
| 2026/06/19 | 69 |
| 2026/06/20 | 66 |
| 2026/06/21 | 69 |
| 2026/06/22 | 69 |
| 2026/06/23 | 73 |
| 2026/06/24 | 70 |
| 2026/06/25 | 69 |
| 2026/06/26 | 69 |
| 2026/06/27 | 68 |
| 2026/06/28 | 68 |
| 2026/06/29 | 71 |
| 2026/06/30 | 71 |
Copyright © Adthena. All rights reserved.
June began with 73 advertisers, fluctuating throughout the month. Peaks reached 79 on June 7, but declined to 66 by June 18. The month concluded with 71 advertisers.
